Astrogliosis in epilepsy leads to overexpression of adenosine kinase, resulting in seizure aggravation

Brain

Volumn 128, Issue 10, 2005, Pages 2383-2395

  Fedele, Denise E ^a,b   Gouder, Nicolette ^a   Güttinger, Martin ^a   Gabernet, Laetitia ^a   Scheurer, Louis ^a   Rülicke, Thomas ^a   Crestani, Florence ^a   Boison, Detlev ^a,b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b ETH ZURICH   (Switzerland)

Author keywords

Adenosine; Adenosine kinase; Astrogliosis; Epilepsy; Transgenic mice

Indexed keywords

ADENOSINE KINASE; ADENOSINE KINASE INHIBITOR; KAINIC ACID; METHYLTESTOSTERONE; UBIQUITIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; BRAIN CORTEX; BRAIN FUNCTION; DISEASE SEVERITY; ENZYME ACTIVITY; EPILEPSY; HIPPOCAMPUS; LOCOMOTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYRAMIDAL NERVE CELL; SEIZURE; TEMPORAL LOBE; TEMPORAL LOBE EPILEPSY; TRANSGENE; UPREGULATION; WILD TYPE;

ADENOSINE KINASE; ANIMALS; ASTROCYTES; BEHAVIOR, ANIMAL; BRAIN; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; ELECTROENCEPHALOGRAPHY; ENZYME INHIBITORS; EPILEPSY, TEMPORAL LOBE; GLIOSIS; HIPPOCAMPUS; KAINIC ACID; LOCOMOTION; MALE; MICE; MICE, TRANSGENIC; NEURONS; TRANSGENES; TUBERCIDIN; UP-REGULATION;

EID: 26044440838     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awh555     Document Type: Article

References (34)

1. Boison D. Adenosine and epilepsy: from therapeutic rationale to new therapeutic strategies. Neuroscientist 2005; 11: 25-36.
2. Boison D, Scheurer L, Tseng JL, Aebischer P, Mohler H. Seizure suppression in kindled rats by intraventricular grafting of an adenosine releasing synthetic polymer. Exp Neurol 1999; 160: 164-74.
3. Boison D, Scheurer L, Zumsteg V, Rülicke T, Litynski P, Fowler B, et al. Neonatal hepatic steatosis by disruption of the adenosine kinase gene. Proc Natl Acad Sci USA 2002; 99: 6985-90.
4. Bontemps F, Van den Berghe G, Hers HG. Evidence for a substrate cycle between AMP and adenosine in isolated hepatocytes. Proc Natl Acad Sci USA 1983; 80: 2829-33.
5. De Sarro G, De Sarro A, Di Paola ED, Bertorelli R. Effects of adenosine receptor agonists and antagonists on audiogenic seizure-sensible DBA/2 mice. Eur J Pharmacol 1999; 371: 137-45.
6. Delaney SM, Geiger JD. Brain regional levels of adenosine and adenosine nucleotides in rats killed by high-energy focused microwave irradiation. J Neurosci Methods 1996; 64: 151-6.
7. Dragunow M, Robertson HA. 8-Cyclopentyl 1,3-dimethylxanthine prolongs epileptic seizures in rats. Brain Res 1987; 417: 377-9.
8. Dunwiddie TV. Adenosine and suppression of seizures. Adv Neurol 1999; 79: 1001-10.
9. Dunwiddie TV, Masino SA. The role and regulation of adenosine in the central nervous system. Annu Rev Neurosci 2001; 24: 31-55.
10. During MJ, Spencer DD. Adenosine: a potential mediator of seizure arrest and postictal refractoriness. Ann Neurol 1992; 32: 618-24.
11. Etherington LA, Frenguelli BG. Endogenous adenosine modulates epilepti-form activity in rat hippocampus in a receptor subtype-dependent manner. Eur J Neurosci 2004; 19: 2539-50.
12. Fedele DE, Koch P, Brüstle O, Scheurer L, Simpson EM, Mohler H, et al. Engineering embryonic stem cell derived glia for adenosine delivery. Neurosci Lett 2004; 370: 160-5.
13. Fredholm BB. Adenosine and neuroprotection. Int Rev Neurobiol 1997; 40: 259-80.
14. Fredholm BB, Battig K, Holmen J, Nehlig A, Zvartau EE. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 1999; 51: 83-133.
15. Fredholm BB, Chen JF, Masino SA, Vaugeois JM. Actions of adenosine at its receptors in the CNS: insights from knockouts and drugs. Annu Rev Pharmacol Toxicol 2005; 45: 385-412.
16. 1 receptor activation in a mouse model of pharmacoresistant epilepsy. Epilepsia 2003; 44: 877-85.
17. Gouder N, Scheurer L, Fritschy J-M, Boison D. Overexpression of adenosine kinase in epileptic hippocampus contributes to epileptogenesis. J Neurosci 2004; 24: 692-701.
18. Huber A, Padrun V, Deglon N, Aebischer P, Mohler H, Boison D. Grafts of adenosine-releasing cells suppress seizures in kindling epilepsy. Proc Natl Acad Sci USA 2001; 98: 7611-6.
19. Johansson B, Halldner L, Dunwiddie TV, Masino Sa, Poelchen W, Gimenez-Llort L, et al. Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor. Proc Natl Acad Sci USA 2001; 98: 9407-12.
20. Kowaluk EA, Jarvis MF. Therapeutic potential of adenosine kinase inhibitors. Expert Opin Investig Drugs 2000; 9: 551-64.
21. Mathews, II, Erion MD, Ealick SE. Structure of human adenosine kinase at 1.5 angstrom resolution. Biochemistry 1998; 37: 15607-20.
22. McGaraughty S, Cowart M, Jarvis MF, Berman RF. Anticonvulsant and antinociceptive actions of novel adenosine kinase inhibitors. Curr Top Med Chem 2005; 5: 43-58.
23. McNally T, Helfrich RJ, Cowart M, Dorwin SA, Meuth JL, Idler KB, et al. Cloning and expression of the adenosine kinase gene from rat and human tissues. Biochem Biophys Res Commun 1997; 231: 645-50.
24. Moore KA, Nicoll RA, Schmitz D. Adenosine gates synaptic plasticity at hippocampal mossy fiber synapses. Proc Natl Acad Sci USA 2003; 100: 14397-402.
25. Pak MA, Haas HL, Decking UKM, Schrader J. Inhibition of adenosine kinase increases endogenous adenosine and depresses neuronal activity in hippocampal slices. Neuropharmacology 1994; 33: 1049-53.
26. Popoli P, Reggio R, Pezzola A, Fuxe K, Ferre S. Adenosine A1 and A2A receptor antagonists stimulate motor activity: evidence for an increased effectiveness in aged rats. Neurosci Lett 1998; 251: 201-4.
27. Rebola N, Coelho JE, Costenla AR, Lopes LV, Parada A, Oliveira CR, et al. Decrease of adenosine A1 receptor density and of adenosine neuromodulation in the hippocampus of kindled rats. Eur J Neurosci 2003; 18: 820-8.
28. Schorpp M, Jager R, Schellander K, Schenkel J, Wagner EF, Weiher H, et al. The human ubiquitin C promoter directs high ubiquitous expression of transgenes in mice. Nucleic Acids Res 1996; 24: 1787-8.
29. Svenningsson P, Nomikos GG, Fredholm BB. The stimulatory action and the development of tolerance to caffeine is associated with alterations in gene expression in specific brain regions. J Neurosci 1999; 19: 4011-22.
30. 6-cyclopentyl adenosine and 8-cyclopentyl-1,3-dipropylxanthine on N-methyl-D-aspartate induced seizures in mice. Eur J Pharmacol 1993; 249: 265-70.
31. Wiesner JB, Ugarkar BG, Castellino AJ, Barankiewicz J, Dumas DP, Gruber HE, et al. Adenosine kinase inhibitors as a novel approach to anticonvulsant therapy. J Pharmacol Exp Ther 1999; 289: 1669-77.
32. Young D, Dragunow M. Status epilepticus may be caused by loss of adenosine anticonvulsant mechanisms. Neuroscience 1994; 58: 245-61.
33. Zhu PJ, Krnjevic K. Endogenous adenosine deaminase does not modulate synaptic transmission in rat hippocampal slices under normoxic or hypoxic conditions. Neuroscience 1994; 63: 489-97.
34. Zumsteg V, Boison D. The use of real-time PCR with fluorogenic probes for the rapid selection of mutant neuroectodermal grafts. J Neurosci Methods 2002; 120: 85-94.